Publication | Closed Access

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Radiation MedicineRadiation TherapyMedicineProstatic DiseaseOncologyRadiation OncologyTreatment VerificationUltra-hypofractionated VersusPhase 3RadiologyHealth Sciences